These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 31277513)

  • 1. Lessons on Differential Neuronal-Death-Vulnerability from Familial Cases of Parkinson's and Alzheimer's Diseases.
    Franco R; Navarro G; Martínez-Pinilla E
    Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31277513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shared mechanisms of neurodegeneration in Alzheimer's disease and Parkinson's disease.
    Xie A; Gao J; Xu L; Meng D
    Biomed Res Int; 2014; 2014():648740. PubMed ID: 24900975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of the mitochondrial tRNA(A4336G) mutation with Alzheimer's and Parkinson's diseases.
    Egensperger R; Kösel S; Schnopp NM; Mehraein P; Graeber MB
    Neuropathol Appl Neurobiol; 1997 Aug; 23(4):315-21. PubMed ID: 9292870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular and molecular mechanisms underlying perturbed energy metabolism and neuronal degeneration in Alzheimer's and Parkinson's diseases.
    Mattson MP; Pedersen WA; Duan W; Culmsee C; Camandola S
    Ann N Y Acad Sci; 1999; 893():154-75. PubMed ID: 10672236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Commonalities in the genetics of Alzheimer's disease and Parkinson's disease.
    Grünblatt E
    Expert Rev Neurother; 2008 Dec; 8(12):1865-77. PubMed ID: 19086884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
    Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
    Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Gene diagnosis of Alzheimer's disease and Parkinson's disease].
    Tanaka S
    Rinsho Byori; 2002 Oct; 50(10):965-9. PubMed ID: 12451676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging pathways to neurodegeneration: Dissecting the critical molecular mechanisms in Alzheimer's disease, Parkinson's disease.
    Tan SH; Karri V; Tay NWR; Chang KH; Ah HY; Ng PQ; Ho HS; Keh HW; Candasamy M
    Biomed Pharmacother; 2019 Mar; 111():765-777. PubMed ID: 30612001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current Concepts of Neurodegenerative Mechanisms in Alzheimer's Disease.
    Magalingam KB; Radhakrishnan A; Ping NS; Haleagrahara N
    Biomed Res Int; 2018; 2018():3740461. PubMed ID: 29707568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fatal attractions: abnormal protein aggregation and neuron death in Parkinson's disease and Lewy body dementia.
    Trojanowski JQ; Goedert M; Iwatsubo T; Lee VM
    Cell Death Differ; 1998 Oct; 5(10):832-7. PubMed ID: 10203692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene therapy and cell reprogramming for the aging brain: achievements and promise.
    Pardo J; Morel GR; Astiz M; Schwerdt JI; León ML; Rodríguez SS; Hereñú CB; Goya RG
    Curr Gene Ther; 2014 Feb; 14(1):24-34. PubMed ID: 24450294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vulnerability of cortical neurons to Alzheimer's and Parkinson's diseases.
    Braak H; Rüb U; Schultz C; Del Tredici K
    J Alzheimers Dis; 2006; 9(3 Suppl):35-44. PubMed ID: 16914843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].
    Hattori N
    Rinsho Shinkeigaku; 2004; 44(4-5):241-62. PubMed ID: 15287506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the Common Molecular Basis in Alzheimer's and Parkinson's Diseases.
    Rana P; Franco EF; Rao Y; Syed K; Barh D; Azevedo V; Ramos RTJ; Ghosh P
    Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31366155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miRNAs Identify Shared Pathways in Alzheimer's and Parkinson's Diseases.
    Sadlon A; Takousis P; Alexopoulos P; Evangelou E; Prokopenko I; Perneczky R
    Trends Mol Med; 2019 Aug; 25(8):662-672. PubMed ID: 31221572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The regulatory role of α-synuclein and parkin in neuronal cell apoptosis; possible implications for the pathogenesis of Parkinson's disease.
    Yasuda T; Mochizuki H
    Apoptosis; 2010 Nov; 15(11):1312-21. PubMed ID: 20221696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential modification of dopamine transporter and tyrosine hydroxylase mRNAs in midbrain of subjects with Parkinson's, Alzheimer's with parkinsonism, and Alzheimer's disease.
    Joyce JN; Smutzer G; Whitty CJ; Myers A; Bannon MJ
    Mov Disord; 1997 Nov; 12(6):885-97. PubMed ID: 9399211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation in the alpha-synuclein gene and sporadic Parkinson's disease, Alzheimer's disease, and dementia with lewy bodies.
    Higuchi S; Arai H; Matsushita S; Matsui T; Kimpara T; Takeda A; Shirakura K
    Exp Neurol; 1998 Sep; 153(1):164-6. PubMed ID: 9743579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alzheimer's disease selective vulnerability and modeling in transgenic mice.
    Götz J; Schonrock N; Vissel B; Ittner LM
    J Alzheimers Dis; 2009; 18(2):243-51. PubMed ID: 19584440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying the Association Between Alzheimer's Disease and Parkinson's Disease Using Genome-Wide Association Studies and Protein-Protein Interaction Network.
    Liu G; Bao X; Jiang Y; Liao M; Jiang Q; Feng R; Zhang L; Ma G; Chen Z; Wang G; Wang R; Zhao B; Li K
    Mol Neurobiol; 2015 Dec; 52(3):1629-1636. PubMed ID: 25370933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.